Direct SLT for pseudoexfoliation glaucoma
Part of Eyes & vision clinical trials.
This trial tests a laser treatment called direct SLT for people with pseudoexfoliation glaucoma. It aims to see if the laser is safe and effective at lowering eye pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pseudoexfoliation glaucoma.
- Your eye pressure is between 18 and 35 mmHg, either without treatment or after stopping your eye drops safely.
- You have not had any prior glaucoma laser or surgery in the eye being treated.
- Your vision is at least 20/40 in the study eye, and your visual field test is reliable.
- You are able to attend all follow-up visits and can safely stop your current eye drops.
- You are not pregnant and do not have any serious health problems that would prevent you from finishing the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares cataract surgery (phacoemulsification) versus a laser treatment (SLT) as the first treatment for pseudoexfoliation glaucoma. It aims to find which approach lowers eye pressure and helps prevent progression for people with early disease and cataracts.
This study is for people who already joined an earlier selective laser eye treatment trial and were able to be followed without needing stronger additional treatments. It looks at the best plan for repeating the laser treatment when appropriate.
This study tests a specific eye laser treatment (micropulse) for people with open-angle or pseudoexfoliation glaucoma. It may help lower eye pressure, and the study also checks whether patients can follow the treatment plan and follow-up visits.
This study tests whether a laser treatment helps keep eye pressure stable in people with early glaucoma or high eye pressure who have not used any eye drops or medications before. It may be a good option if you are looking for a treatment that doesn't require daily eye drops.
This trial tests a type of laser treatment (DSLT) for people of Asian descent who have normal tension glaucoma, where eye pressure stays below 21 mmHg. It aims to see if this laser can help control the disease and possibly reduce the need for eye drops.
This trial tests a new type of laser treatment (DSLT) for patients with glaucoma or high eye pressure who have already had a similar laser treatment (SLT) before. The goal is to see if this new laser approach can lower eye pressure in patients where the first treatment may not have worked well enough.
Hear when a new Pseudoexfoliation Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.